6 matches for your search in the start-up spotlight
rss
BIH Partners With BioLabs to Launch Clinical Incubator
12-May-2025
Aiming to bridge the gap between cutting-edge biomedical research and real-world clinical application, the Berlin Institute of Health at Charité (BIH) entered into an agreement with BioLabs, an internationally known innovation laboratory platform with a network of shared lab and office ...
Spin-off company pinpoints the best time to exercise, sleep and take medicine
24-May-2023
An interdisciplinary team led by Prof. Angelo Relógio, a scientist at Charité’s Molecular Cancer Research Center (MKFZ) and Institute for Theoretical Biology and the MSH Medical School Hamburg, has developed a non-invasive method for profiling a person’s unique circadian rhythm. Starting with a ...
“Nephrolytix’s aim is to set a new gold standard for kidney function diagnostics that will help millions of patients”
24-May-2022
Acute kidney injury (AKI) is commonly seen in hospitals. It entails the rapid deterioration of kidney function, a high disease burden, and leads in some cases to death. The team at Nephrolytix GmbH, a new spin-off of Charité – Universitätsmedizin Berlin, has developed a process with the potential ...
Device prints a perfectly fitting bandage that can be used to close large wounds
22-Feb-2022
Scientists at the Berlin Institute of Health at Charité (BIH) have teamed up with a company called Cellbricks to develop a 3D printer that can produce a biological wound closure: Using a mix of gelatin and skin cells, the device prints a perfectly fitting bandage that can be used to close large ...
Drug targets were identified
23-Dec-2020
Like all viruses, the novel coronavirus is dependent on help from the human host cell. Proteins are the functional units of the cell and enable the virus to enter the host cell or help the virus to replicate. Scientists from the Berlin Institute of Health (BIH), Charité – Universitätsmedizin ...
BIH Digital Health Accelerator guides Aignostics GmbH through its spin-off
27-Apr-2020
The usual way to determine if a suspicious lump is cancerous involves microscopic examination in a pathology laboratory. To ease the workload of pathologists who face a rising number of cancer cases and increasingly finer molecular details and to enable tailored treatments, scientists at the ...
